176 related articles for article (PubMed ID: 12115695)
1. Spontaneous and augmented growth of axons in the primate spinal cord: effects of local injury and nerve growth factor-secreting cell grafts.
Tuszynski MH; Grill R; Jones LL; McKay HM; Blesch A
J Comp Neurol; 2002 Jul; 449(1):88-101. PubMed ID: 12115695
[TBL] [Abstract][Full Text] [Related]
2. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells.
Grill RJ; Blesch A; Tuszynski MH
Exp Neurol; 1997 Dec; 148(2):444-52. PubMed ID: 9417824
[TBL] [Abstract][Full Text] [Related]
3. Axonal responses to cellularly delivered NT-4/5 after spinal cord injury.
Blesch A; Yang H; Weidner N; Hoang A; Otero D
Mol Cell Neurosci; 2004 Oct; 27(2):190-201. PubMed ID: 15485774
[TBL] [Abstract][Full Text] [Related]
4. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition.
Jones LL; Sajed D; Tuszynski MH
J Neurosci; 2003 Oct; 23(28):9276-88. PubMed ID: 14561854
[TBL] [Abstract][Full Text] [Related]
5. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination.
Blesch A; Tuszynski MH
J Comp Neurol; 2003 Dec; 467(3):403-17. PubMed ID: 14608602
[TBL] [Abstract][Full Text] [Related]
6. Growth-modulating molecules are associated with invading Schwann cells and not astrocytes in human traumatic spinal cord injury.
Buss A; Pech K; Kakulas BA; Martin D; Schoenen J; Noth J; Brook GA
Brain; 2007 Apr; 130(Pt 4):940-53. PubMed ID: 17314203
[TBL] [Abstract][Full Text] [Related]
7. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury.
Lu P; Jones LL; Tuszynski MH
Exp Neurol; 2005 Feb; 191(2):344-60. PubMed ID: 15649491
[TBL] [Abstract][Full Text] [Related]
8. The ability of human Schwann cell grafts to promote regeneration in the transected nude rat spinal cord.
Guest JD; Rao A; Olson L; Bunge MB; Bunge RP
Exp Neurol; 1997 Dec; 148(2):502-22. PubMed ID: 9417829
[TBL] [Abstract][Full Text] [Related]
9. Failure of Schwann cells as supporting cells for adult neural progenitor cell grafts in the acutely injured spinal cord.
Vroemen M; Caioni M; Bogdahn U; Weidner N
Cell Tissue Res; 2007 Jan; 327(1):1-13. PubMed ID: 16941122
[TBL] [Abstract][Full Text] [Related]
10. [Effect of pre-degeneration of peripheral nerves on plasticity of cultivated Schwann cells and their cell number in vitro].
Fansa H; Keilhoff G; Frerichs O; Wolf G; Schneider W
Handchir Mikrochir Plast Chir; 1999 Nov; 31(6):367-72. PubMed ID: 10637725
[TBL] [Abstract][Full Text] [Related]
11. Grafts of genetically modified Schwann cells to the spinal cord: survival, axon growth, and myelination.
Tuszynski MH; Weidner N; McCormack M; Miller I; Powell H; Conner J
Cell Transplant; 1998; 7(2):187-96. PubMed ID: 9588600
[TBL] [Abstract][Full Text] [Related]
12. Axon regeneration through scars and into sites of chronic spinal cord injury.
Lu P; Jones LL; Tuszynski MH
Exp Neurol; 2007 Jan; 203(1):8-21. PubMed ID: 17014846
[TBL] [Abstract][Full Text] [Related]
13. Delayed implantation of intramedullary chitosan channels containing nerve grafts promotes extensive axonal regeneration after spinal cord injury.
Nomura H; Baladie B; Katayama Y; Morshead CM; Shoichet MS; Tator CH
Neurosurgery; 2008 Jul; 63(1):127-41; discussion 141-3. PubMed ID: 18728578
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration.
Tuszynski MH; Roberts J; Senut MC; U HS; Gage FH
Gene Ther; 1996 Apr; 3(4):305-14. PubMed ID: 8732162
[TBL] [Abstract][Full Text] [Related]
15. Immunolocalization studies of putative guidance molecules used by axons and growth cones of intersegemental interneurons in the chick embryo spinal cord.
Shiga T; Oppenheim RW
J Comp Neurol; 1991 Aug; 310(2):234-52. PubMed ID: 1720141
[TBL] [Abstract][Full Text] [Related]
16. Glial cell line-derived neurotrophic factor added to a sciatic nerve fragment grafted in a spinal cord gap ameliorates motor impairments in rats and increases local axonal growth.
Guzen FP; de Almeida Leme RJ; de Andrade MS; de Luca BA; Chadi G
Restor Neurol Neurosci; 2009; 27(1):1-16. PubMed ID: 19164849
[TBL] [Abstract][Full Text] [Related]
17. [FGF-2-treatment improves locomotor function via axonal regeneration in the transected rat spinal cord].
Furukawa S; Furukawa Y
Brain Nerve; 2007 Dec; 59(12):1333-9. PubMed ID: 18095482
[TBL] [Abstract][Full Text] [Related]
18. Delivery of hyper-interleukin-6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth.
Lacroix S; Chang L; Rose-John S; Tuszynski MH
J Comp Neurol; 2002 Dec; 454(3):213-28. PubMed ID: 12442313
[TBL] [Abstract][Full Text] [Related]
19. NGF message and protein distribution in the injured rat spinal cord.
Brown A; Ricci MJ; Weaver LC
Exp Neurol; 2004 Jul; 188(1):115-27. PubMed ID: 15191808
[TBL] [Abstract][Full Text] [Related]
20. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries.
Davies JE; Tang X; Denning JW; Archibald SJ; Davies SJ
Eur J Neurosci; 2004 Mar; 19(5):1226-42. PubMed ID: 15016081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
